Tadeusz Hayduk Wroblewski

Mr. Tadeusz Hayduk Wroblewski

Neural and Behavioral Science, SUNY Downstate Medical Center, Brooklyn, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in EMBO Reports
Verified
Journal Article
Open access
PDF file
ABAdam Begeman
Adam Begeman
ASAhyun Son
Ahyun Son
TLTheodore J Litberg
Theodore J Litberg
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
TGThane Gehring
Thane Gehring
Scott of HorowitzScott of Horowitz
Scott of Horowitz
Maintaining proteome health is important for cell survival. Nucleic acids possess the ability to prevent protein aggregation more efficiently than traditional chaperone proteins. In this study, we explore the sequence specificity of the chaperone activity of nucleic acids. Evaluating over 500 nucleic acid sequences’ effects on protein aggregation, we show that the holdase chaperone effect of nucleic acids is sequence‐dependent. G‐Quadruplexes prevent protein aggregation via quadruplex:protein oligomerization. They also increase the folded protein level of a biosensor in E. coli . These observations contextualize recent reports of quadruplexes playing important roles in aggregation‐related diseases, such as fragile X and amyotrophic lateral sclerosis (ALS), and provide evidence that nucleic acids have the ability to modulate the folding environment of E. coli .

Verified
Journal Article
Open access
PDF file
PTPhilip David Tatman
Philip David Tatman
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
AFAnthony Rocco Fringuello
Anthony Rocco Fringuello
SSSamuel R. Scherer
Samuel R. Scherer
WFWill Foreman
Will Foreman
DOD. Ryan Ormond
D. Ryan Ormond
Background: Meningiomas are the most common primary central nervous system tumors. 20–30% of these tumors are considered high-grade and associated with poor prognosis and high recurrence rates. Despite the high occurrence of meningiomas, there are no FDA-approved compounds for the treatment of these tumors. Methods: In this study, we screened patient-cultured meningiomas with an epigenetic compound library to identify targetable mechanisms for the potential treatment of these tumors. Meningioma cell cultures were generated directly from surgically resected patient tumors and were cultured on a neural matrix. Cells were treated with a library of compounds meant to target epigenetic functions. Results: Although each tumor displayed a unique compound sensitivity profile, Panobinostat, LAQ824, and HC toxin were broadly effective across most tumors. These three compounds are broad-spectrum Histone Deacetylase (HDAC) inhibitors which target class I, IIa, and IIb HDACs. Panobinostat was identified as the most broadly effective compound, capable of significantly decreasing the average cell viability of the sample cohort, regardless of tumor grade, recurrence, radiation, and patient gender. Conclusions: These findings strongly suggest an important role of HDACs in meningioma biology and as a targetable mechanism. Additional validation studies are necessary to confirm these promising findings, as well to identify an ideal HDAC inhibitor candidate to develop for clinical use.

Verified
Journal Article
Open access
PDF file
AFAnthony Rocco Fringuello
Anthony Rocco Fringuello
PTPhilip David Tatman
Philip David Tatman
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
JTJohn A. Thompson
John A. Thompson
XYXiaoli Yu
Xiaoli Yu
MGMichael Graner
Michael Graner
Background: A major contributor to disability after hemorrhagic stroke is secondary brain damage induced by the inflammatory response. Following stroke, global increases in numerous cytokines—many associated with worse outcomes—occur within the brain, cerebrospinal fluid, and peripheral blood. Extracellular vesicles (EVs) may traffic inflammatory cytokines from damaged tissue within the brain, as well as peripheral sources, across the blood–brain barrier, and they may be a critical component of post-stroke neuroinflammatory signaling. Methods: We performed a comprehensive analysis of cytokine concentrations bound to plasma EV surfaces and/or sequestered within the vesicles themselves. These concentrations were correlated to patient acute neurological condition by the Glasgow Coma Scale (GCS) and to chronic, long-term outcome via the Glasgow Outcome Scale-Extended (GOS-E). Results: Pro-inflammatory cytokines detected from plasma EVs were correlated to worse outcomes in hemorrhagic stroke patients. Anti-inflammatory cytokines detected within EVs were still correlated to poor outcomes despite their putative neuroprotective properties. Inflammatory cytokines macrophage-derived chemokine (MDC/CCL2), colony stimulating factor 1 (CSF1), interleukin 7 (IL7), and monokine induced by gamma interferon (MIG/CXCL9) were significantly correlated to both negative GCS and GOS-E when bound to plasma EV membranes. Conclusions: These findings correlate plasma-derived EV cytokine content with detrimental outcomes after stroke, highlighting the potential for EVs to provide cytokines with a means of long-range delivery of inflammatory signals that perpetuate neuroinflammation after stroke, thus hindering recovery.

17 February 2025 in American Journal of Epidemiology
Verified
Journal Article
Closed access
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
FOFavour Ononogbu-Uche
Favour Ononogbu-Uche
PJPemla Jagtiani
Pemla Jagtiani
MRMarie-Claire Roberts
Marie-Claire Roberts
TBTim B Bigdeli
Tim B Bigdeli
EBErnest J Barthélemy
Ernest J Barthélemy
Traumatic brain injury (TBI) is a major public health concern affecting millions of people each year. Disparities in TBI outcomes based on social determinants of health (SDoH), such as race and socioeconomic position, highlight the need to explore the causative structural inequities. We employed a socio-epidemiologic approach, with particular focus on the putative role of structural racism, to investigate the prevalence, sociodemographic patterns, and neuropsychiatric outcomes of TBI in the All of Us database. This study included 11 286 individuals with a documented TBI diagnosis, determined based on a curated phenotype definition using the International Statistical Classification of Diseases Clinical Modification criteria. Outcome measures included TBI prevalence and sociodemographic distribution; TBI severity; and neuropsychiatric diagnoses related to TBI. Nearly equivalent TBI prevalences were observed across racial categories. Black participants with TBI had higher socioeconomic deprivation indices and higher prevalence of certain neuropsychiatric conditions, such as substance use disorders and headache disorders, compared to White participants. This study underscores the importance of considering SDoH, particularly race and socioeconomic position, in TBI research. These findings highlight the need for efforts to address structural inequities that impact disparities in TBI and call for future research investigating how healthcare practices relate to disparities in TBI outcomes. This article is part of a Special Collection on Methods in Social Epidemiology.

3 March 2022 in World Neurosurgery
Verified
Journal Article
Closed access
PTPhilip D. Tatman
Philip D. Tatman
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
AFAnthony R. Fringuello
Anthony R. Fringuello
SSSamuel R. Scherer
Samuel R. Scherer
WFWilliam B. Foreman
William B. Foreman
MGMichael Graner
Michael Graner

21 December 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Tadeusz Hayduk WroblewskiTadeusz Hayduk Wroblewski
Tadeusz Hayduk Wroblewski
MKMert Karabacak
Mert Karabacak
CSCarina Seah
Carina Seah
RYRaymund Yong
Raymund Yong
KMKonstantinos Margetis
Konstantinos Margetis
Background/Objectives: Glioblastoma (GBM) is the most common malignant primary central nervous system tumor with extremely poor prognosis and survival outcomes. Non-invasive methods like radiomic feature extraction, which assess sub-visual imaging features, provide a potentially powerful tool for distinguishing molecular profiles across groups of patients with GBM. Using consensus clustering of MRI-based radiomic features, this study aims to investigate differential gene expression profiles based on radiomic clusters. Methods: Patients from the TCGA and CPTAC datasets (n = 114) were included in this study. Radiomic features including T1, T1 with contrast, T2, and FLAIR MRI sequences were extracted using PyRadiomics. Selected radiomic features were then clustered using ConsensusClusterPlus (k-means base algorithm and Euclidean distance), which iteratively subsamples and clusters 80% of the data to identify stable clusters by calculating the frequency in which each patient is a member of a cluster across iterations. Gene expression data (available for n = 69 patients) was analyzed using differential gene expression (DEG) and gene set enrichment (GSEA) approaches, after batch correction using ComBat-seq. Results: Three distinct clusters were identified based on the relative consensus matrix and cumulative distribution plots (Cluster 1, n = 25; Cluster 2, n = 46; Cluster 3, n = 43). No significant differences in patient demographic characteristics, MGMT methylation status, tumor location, or overall survival were identified across clusters. Differentially expressed genes were identified in Cluster 1, which have been previously associated with GBM prognosis, recurrence, and treatment sensitivity. GSEA of Cluster 1 showed an enrichment of genes upregulated for immune-related and DNA metabolism pathways and genes downregulated in pathways associated with protein and histone deacetylation. Clusters 2 and 3 exhibited fewer DEGs which failed to reach significance after multiple testing corrections. Conclusions: Consensus clustering of radiomic features revealed unique gene expression profiles in the GBM cohort which likely represent subtle differences in tumor biology and radiosensitivity that are not visually discernible, underscoring the potential of radiomics to serve as a non-invasive alternative for identifying GBM molecular heterogeneity. Further investigation is still required to validate these findings and their clinical implications.